TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00450450 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01412346 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01430156 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT02059460 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01930747 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT00044642 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01717807 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01717807 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01028365 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00006903 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00260403 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02665559 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02665559 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT02665559 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03244709 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00093899 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01263418 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT02697786 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02528656 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02762682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01950845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04060550 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04537507 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT00508625 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT02147340 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03460483 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02967497 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02967497 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02967497 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04369651 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03690115 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03690115 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03690115 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03690115 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00213798 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT02751996 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00001596 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02341053 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00211445 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02036463 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02422628 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01817998 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03433768 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03433768 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00113217 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00113217 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00113217 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT00113217 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT00113217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00113217 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00113217 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02450903 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03581344 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT01148940 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01409564 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT02282020 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02257788 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03804879 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02269813 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02269813 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03764137 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04416464 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03686163 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00075140 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03857243 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00330564 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT03124914 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03512743 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02668133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02405247 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02713984 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02323126 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03735433 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02291198 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00860964 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00556036 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04404751 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00461682 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04101357 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT01778933 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT00696176 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02936791 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT02120729 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02990390 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00399360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04487639 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02581449 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02012998 — Predictive Biomarker (PRD): HEXA mRNA
Genes: HEXA
Study NCT05601258 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03026452 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03026452 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03187093 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01477606 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03311815 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study NCT03311815 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT03311815 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT03311815 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03311815 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03311815 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study NCT03311815 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03311815 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT03311815 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03311815 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03311815 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03311815 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT03311815 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03311815 — Predictive Biomarker (PRD): PTPN11 mRNA
Genes: PTPN11; PTP2C; SHPTP2
Study NCT03311815 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT03311815 — Predictive Biomarker (PRD): SETBP1 mRNA
Genes: SETBP1; KIAA0437
Study NCT03311815 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT03311815 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03311815 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study NCT03311815 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03589950 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03589950 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT00894452 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01610947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01399151 — Safety Biomarker (SAF): Interleukin 1
Study NCT03989557 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT04190615 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04563689 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02459132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00549302 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00549302 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03520231 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT01404390 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03103386 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00788632 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00528385 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00528385 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03913793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01690247 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00937157 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study NCT01116869 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02946645 — Predictive Biomarker (PRD): KNG1 mRNA
Genes: KNG1; BDK; KNG
Study NCT00144976 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00144976 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03231033 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03231033 — Predictive Biomarker (PRD): ABCG1 mRNA
Genes: ABCG1; ABC8; WHT1
Study NCT01961323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00702819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00702819 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01569646 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04122092 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01315067 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00268996 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT02211521 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04573816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04304391 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study NCT04304391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01325974 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05058443 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00380614 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01269424 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02511366 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01344161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02953314 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02953314 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT03021265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04217473 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04217473 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00035620 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT03061331 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02559479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03971799 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03907293 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT00412022 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01909050 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01909050 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT00003150 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03280290 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03280290 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT03420469 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01388621 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01388621 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01540526 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02048644 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT06363812 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06363812 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06363812 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02278588 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02278588 — Safety Biomarker (SAF): BDNF
Study NCT00763308 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03952000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03952000 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03952000 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01195506 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT01195506 — Predictive Biomarker (PRD): VEGFC mRNA
Genes: VEGFC
Study NCT01195506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01432886 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00005170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02068833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00045500 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT04202692 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04090840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01808053 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01808053 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01522989 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT00662610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03940664 — Predictive Biomarker (PRD): CD160 mRNA
Genes: CD160; BY55
Study NCT02187484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06125015 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT00708162 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT00065507 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00517621 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT01813578 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00705081 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01058889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04551898 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01230801 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03578029 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study NCT01942291 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT00541073 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01444326 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04653805 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03532919 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01668550 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01668550 — Pharmacodynamic Biomarker (PDY): Crk-like protein
Genes: CRKL
Study NCT01668550 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT02318511 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03495323 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT01619683 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00262808 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01396720 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01396720 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT03638024 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02601950 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03804944 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03804944 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00330941 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04446377 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00007111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04517253 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT01490476 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT02614950 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02684266 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04034173 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03403595 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05548829 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04053855 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT04053855 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study NCT04053855 — Predictive Biomarker (PRD): CD81 mRNA
Genes: CD81; TAPA1; TSPAN28
Study NCT04045340 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT00423150 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03300479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04111679 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02853591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02853591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01045889 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01399138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04840238 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01859533 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05070117 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02014896 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT00016146 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT04599920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00810290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01953341 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03454919 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03454919 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study NCT03454919 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT01011660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01770379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02074631 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01433601 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04926909 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT04926909 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01166724 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT01626560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02808026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05283057 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03533179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03577704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01914744 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02457910 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K